RHONDA CLARK: Open Payments
NPI 1154379451 · BASSETT, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 14 payments from 9 companies in 2025. Trend: 2023 $221 · 2024 $379 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
Products named: GVOKE HYPOPEN, FARXIGA, OTEZLA, Dexcom G6 Transmitter, ELIQUIS, BREZTRI, MOUNJARO, Rybelsus.
Industry payments across VA — which companies pay providers there.
